News and Articles

Laser Beam Beauty: 'The Complete Guide to Laser Hair Removal' DVD released by Aesthetic VideoSource

Dermatologists Mark Taylor, M.D. and Christine Whitelaw, M.D. demonstrate http://www.videoshelf.com/laser_hair_removal.html [laser hair removal] on the face, underarms, back, bikini area, and legs.

Read more

BioForm Medical to Present at the 2008 Maxim Group Growth Conference

SAN MATEO, Calif., Oct. 1 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced today that it is scheduled to present at the 2008 Maxim Group Growth Conference on Tuesday, October 7, 2008. Derek Bertocci, Chief Financial Officer of BioForm Medical, is scheduled to provide a corporate overview of the Company at 2:30 p.m. (ET) in New York City.

Read more

338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment

SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced that the pivotal clinical study of Polidocanol, conducted in Germany by BioForm Medical's partner, Chemische Fabrik KREUSSLER & Co. GmbH (Kreussler), successfully met the study primary endpoint and has been submitted to FDA as part of a New Drug Application (NDA) process.

Read more

BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008

SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced its financial results for the fourth quarter and full fiscal year ended June 30, 2008. Net sales were $16.7 million for the quarter ended June 30, 2008 as compared to $15.4 million for the quarter ended June 30, 2007, an increase of $1.3 million or 8.4%. The net loss was $20.0 million for the quarter ended June 30, 2008 as compared to a net loss of $4.9 million for the quarter ended June 30, 2007. Net sales were $67.5 million for fiscal year 2008 as compared to $47.4 million for fiscal year 2007, an increase of $20.1 million or 42.4%. The net loss was $29.5 million for the fiscal year 2008 as compared to $13.6 million for fiscal year 2007. The $20.0 million net loss in the fourth quarter and the $29.5 million net loss for fiscal year 2008 each included an $11.2 million charge for acquired in-process research and development arising from the purchase of substantially all assets of Advanced Cosmetic Intervention, Inc. (ACI) in April 2008.

Read more

Venous Surgery EMR: SonoSoft Chooses Practice Management Solution MPMsoft as its Medical Billing Software

SAN FRANCISCO, Sept. 1 /PRNewswire/ -- As baby boomers age, varicose veins can signal health concerns of not merely unsightly veins, but sometimes painful ulcers that can be a harbinger of a potential for stroke. Fortunately, a fairly simple procedure of laser surgery exists that can reduce the risk of serious complications.

Read more

BioForm Medical to Announce Financial Results for Quarter and Fiscal Year Ended June 30, 2008, and Host Conference Call and Webcast on September 4, 2008

SAN MATEO, Calif., Aug. 22 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced that on Thursday, September 4, 2008, it will report its financial results for its fourth quarter and fiscal year ended June 30, 2008. The Company will issue the earnings press release after the NASDAQ Global Market closes and will hold a conference call with investors at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

Read more

Survey Shows People With Varicose Veins Unaware of Health Risks; Most Never Consider Treatment

CHICAGO, July 29 /PRNewswire/ -- Varicose veins -- unsightly bulging veins in the legs -- force many embarrassed sufferers to cover up, even on the hottest summer days. While often dismissed as a cosmetic issue, varicose veins actually can develop into serious health problems. According to a new survey, many who suffer from varicose veins aren't aware of this and are not seeking treatment for their condition. The survey, sponsored by Vein Clinics of America, found that one in five people reported having varicose veins, and half (48 percent) also experienced aching pain in the legs. Surprisingly, most people (87 percent) reported they have never sought treatment and nearly half (42 percent) do not consider varicose veins to be a serious health issue.

Read more

Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers

SAN MATEO, Calif., June 26 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced the publication of five studies in the June 2008 issue of the Journal of Dermatologic Surgery, a peer-reviewed publication of the American Society of Dermatologic Surgery. The five published clinical and preclinical reports were:

Read more

Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers

SAN MATEO, Calif., June 26 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced the publication of five studies in the June 2008 issue of the Journal of Dermatologic Surgery, a peer-reviewed publication of the American Society of Dermatologic Surgery. The five published clinical and preclinical reports were:

Read more

Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers

SAN MATEO, Calif., June 26 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced the publication of five studies in the June 2008 issue of the Journal of Dermatologic Surgery, a peer-reviewed publication of the American Society of Dermatologic Surgery. The five published clinical and preclinical reports were:

Read more

BioForm Medical to Present at the 2008 Jefferies Second Annual Healthcare Conference

SAN MATEO, Calif., June 20 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced that Steven Basta, Chief Executive Officer of BioForm Medical will present a company overview at the upcoming Jefferies Second Annual Healthcare Conference being held June 24-26th, 2008 in New York. BioForm Medical's presentation will take place on Wednesday, June 25th, 2008 at 8:30 a.m. EDT.

Read more

CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery

ATLANTA and SAN MATEO, Calif., June 10 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), and BioForm Medical, Inc. (Nasdaq: BFRM) today announced that they have received a CE Mark for the use of CryoLife's BioGlue Surgical Adhesive for periosteal fixation following endoscopic browplasty or brow lift, a reconstructive plastic surgery procedure. The CE Mark approval allows the product to be marketed in the European Community (EU).

Read more

Oregon Cosmetic Vein Center Opens in Portland, Among First on West Coast to Offer Brand New, FDA-Approved Procedures and Technologies

PORTLAND, Ore., May 28 /PRNewswire/ -- Today, Dr. F. Douglas Day, M.D., Founder and Medical Director of Day Medical Salon, announced the launch of the Oregon Cosmetic Vein Center (OCVC). The OCVC (http://www.oregoncosmeticveincenter.com) is one of the first West Coast vein clinics to offer the CoolTouch CTEV(R) Vein Removal Procedure and other new, FDA-approved treatments and technologies. The OCVC's investment in the very latest equipment and training delivers better results in fewer visits, a potential savings of money, time and discomfort for clients. The OCVC is conveniently located in the medical suites on the third floor of Portland's Lloyd Center Mall.

Read more

Vein Clinics of America Teams Up with Healthy Skin Portal to Eliminate Unwanted Veins

CHICAGO, May 16 /PRNewswire/ -- For years varicose veins and spider veins have been near impossible to treat. The only solutions available were risky vein removal surgeries such as vein stripping and ambulatory phlebectomy. These procedures carry a high risk for infection, post-operative bleeding, and scarring. Http://www.HealthySkinPortal.com , a leading resource for non-surgical skin care, believes there's an easier way. Healthy Skin Portal has teamed up with Vein Clinics of America to provide safe and effective vein treatment alternatives.

Read more

BioForm Medical Announces Extension of Lock-Up Period

SAN MATEO, Calif., May 5 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced today that lock-up agreements entered into with its underwriters in conjunction with its initial public offering will be extended 18 days beyond the Company's May 1, 2008 earnings release. The lock-up period was due to expire on May 3, but the Company's underwriting agreement provided for an extension, depending on the timing of BioForm Medical's quarterly earnings press release. The first sales of shares restricted by the underwriter's lock-up may take place on Tuesday, May 20, 2008. Approximately 33 million shares will become eligible for sale in the public market upon expiration of the underwriters' lock-up, of which approximately 10 million shares will be freely tradable under Rule 144(b) and the remainder will be held by affiliates and other stockholders subject to the volume and other restrictions of Rule 144.

Read more

BioForm Announces Financial Results for Quarter Ended March 31, 2008, Third Quarter of Fiscal 2008

SAN MATEO, Calif., May 1 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced its financial results for the quarter ended March 31, 2008, which is the Company's third quarter of fiscal year 2008. Net sales were $17.0 million for the quarter ended March 31, 2008 as compared to $12.4 million for the quarter ended March 31, 2007, an increase of $4.6 million or 36.3%. The net loss was $4.5 million for the quarter ended March 31, 2008 as compared to $3.6 million for the quarter ended March 31, 2007. Net sales for the nine months ended March 31, 2008 were $50.8 million, as compared to $32.1 million for the nine months ended March 31, 2007. The net loss was $9.5 million for the nine months ended March 31, 2008 as compared to $8.7 million for the nine months ended March 31, 2007.

Read more

BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology

SAN MATEO, Calif., April 30 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced that it has acquired substantially all of the assets of privately-held, Denver, CO based, Advanced Cosmetic Intervention, Inc. (ACI) and associated technology rights for $12 million cash, plus future royalties and a potential sales-related milestone. This acquisition provides BioForm Medical, a leading medical aesthetics company, with a commercially- available technology for local nerve ablation.

Read more

Getting Beach Ready Calls for More Than Hitting the Gym

CHICAGO, April 16 /PRNewswire/ -- As the summer months approach, so does the desire to look good in that swimsuit. Many Americans these days are choosing to receive cosmetic surgery in early spring in order to ready themselves for the beach.

Read more

BioForm Medical to Announce Financial Results For Quarter Ended March 31, 2008, Third Quarter of Fiscal 2008, and Host Conference Call and Webcast on May 1, 2008

SAN MATEO, Calif., April 10 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced that on Thursday, May 1, 2008, it will report its financial results for the quarter ended March 31, 2008, which is its third quarter fiscal year 2008. The Company will issue the earnings press release after the NASDAQ Global Market closes and will hold a conference call with investors at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

Read more